Quality of life in patients receiving high-dose interferon alfa-2b after resected high-risk melanoma

J Clin Oncol. 2009 Aug 20;27(24):e70; author reply e71. doi: 10.1200/JCO.2009.23.3874. Epub 2009 Jul 20.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Melanoma / drug therapy*
  • Melanoma / psychology*
  • Melanoma / surgery
  • Quality of Life*
  • Recombinant Proteins
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / psychology*
  • Skin Neoplasms / surgery

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins